Teladoc Health Executive Disposes of Stock Following RSU Vesting
Joseph Ronald Catapano, Teladoc Health's Chief Accounting Officer, executed a sale of 653 common shares on July 2, 2026, totaling $5,942. The transaction, priced at $9.10 per share, was necessitated by tax withholding requirements tied to the vesting of restricted stock units. This event occurs against a backdrop of Teladoc's stock performance, whi…